NYSE - Delayed Quote • USD
Humana Inc. (HUM)
At close: April 24 at 4:00 PM EDT
After hours: April 24 at 7:56 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 19 | 19 | 21 | 21 |
| Avg. Estimate | 6.12 | 5.81 | 16.36 | 22.9 |
| Low Estimate | 5.76 | 4.31 | 15.94 | 19 |
| High Estimate | 8.11 | 7.51 | 18.84 | 26.24 |
| Year Ago EPS | 9.38 | 8.94 | 26.09 | 16.36 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 16 | 16 | 17 | 16 |
| Avg. Estimate | 28.47B | 28.04B | 111.87B | 115.01B |
| Low Estimate | 27.44B | 27.39B | 108.91B | 107.78B |
| High Estimate | 29.6B | 28.61B | 113.71B | 123.94B |
| Year Ago Sales | 25.65B | 25.73B | 102.64B | 111.87B |
| Sales Growth (year/est) | 11.00% | 9.00% | 9.00% | 2.80% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | 9.27 | 8.82 | 7.16 | 0.15 |
| EPS Actual | 9.38 | 8.94 | 7.78 | -0.11 |
| Difference | 0.11 | 0.12 | 0.62 | -0.26 |
| Surprise % | 1.20% | 1.40% | 8.70% | -173.30% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 6.12 | 5.81 | 16.36 | 22.9 |
| 7 Days Ago | 6.12 | 5.81 | 16.36 | 23.17 |
| 30 Days Ago | 6.15 | 5.88 | 16.34 | 24.58 |
| 60 Days Ago | 6.18 | 5.95 | 17.07 | 24.82 |
| 90 Days Ago | 9.45 | 9.03 | 29.1 | 34.52 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | -- | 1 | -- |
| Up Last 30 Days | 1 | 1 | 3 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | 1 |
Growth Estimates
| CURRENCY IN USD | HUM | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -34.80% | -- | -- | 1.50% |
| Next Qtr. | -35.00% | -- | -- | 11.40% |
| Current Year | -37.30% | -- | -- | 5.20% |
| Next Year | 40.00% | -- | -- | 13.40% |
| Next 5 Years (per annum) | 2.23% | -- | -- | 11.09% |
| Past 5 Years (per annum) | 10.31% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | Jefferies: Buy to Buy | 4/22/2024 |
| Reiterates | Cantor Fitzgerald: Neutral to Neutral | 4/10/2024 |
| Maintains | Wells Fargo: Overweight to Overweight | 4/8/2024 |
| Reiterates | Cantor Fitzgerald: Neutral to Neutral | 4/4/2024 |
| Maintains | Goldman Sachs: Buy to Buy | 4/3/2024 |
| Maintains | Barclays: Equal-Weight to Equal-Weight | 4/2/2024 |
Related Tickers
CI The Cigna Group
352.28
-0.10%
ELV Elevance Health, Inc.
533.73
+0.15%
UNH UnitedHealth Group Incorporated
487.30
+0.23%
CVS CVS Health Corporation
67.77
-1.07%
CNC Centene Corporation
76.19
+0.46%
MOH Molina Healthcare, Inc.
367.41
+1.15%
OSCR Oscar Health, Inc.
17.59
+1.09%
CLOV Clover Health Investments, Corp.
0.6500
+3.19%
ALHC Alignment Healthcare, Inc.
5.18
0.00%
NEUE NeueHealth, Inc.
6.46
+5.04%